Bioresorbable Collagen Implant Market

Market Overview

Collagen is the resorbable, fully abundant and ubiquitous structural protein in the human body, it plays important roles in development, platelet activation, bones and joint health, wound healing, angiogenesis and for the closure of extraction and graft sites. Bioresorbable collagen implants are biologically absorbed into the body slowly and are not required to be removed after a specific time.

Bioresorbable collagen implants are used to regularize the physiological function in the human body and are considered as an artificial substitute in nature. They are used in various dental, ocular, orthopaedic and vascular surgeries. Bioresorbable collagen implants are used most frequently in dentistry for Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) procedures owing to their certain advantages including their excellent biodegradation without showing any major immune reaction, rapid vascularization and ideal tissue integration and hemostatic property in surgery.

The COVID-19 outbreak has a severe impact on different industries. COVID-19 pandemic led re-routing of the supply chain and change in consumer behaviour and demand due to the significant interventions of governments. COVID-19 has a significant effect on bioresorbable collagen implant market due to patient’s shortfall to hospitals and also due to disturbance in manufacturing and supply of implants. COVID-19 pandemic has changed the dynamics of current market forces and purchasing patterns of implants.

Increasing areas of application mainly in the dental and medical field, new technology expansion, Increasing acquisition strategies and product launch is expected to drive the bioresorbable collagen implant market growth. Manufacturers are investing in the development and commercialization of the bioresorbable collagen implants that are more cost-effective and which will fulfil the patient demand and robust bioresorbable collagen implant market growth. The future advancement and pipeline products in bioresorbable collagen implants are expected to fuel bioresorbable collagen implant market growth.

However, the high cost of treatment, time-consuming approval procedures of implants by regulatory bodies and reimbursement issues might hamper the growth of bioresorbable collagen implants market. Drawbacks of bioresorbable collagen implants such as unpredictable resorption time, difficulty to tack down and technique sensitivity may restrain the growth of the bioresorbable collagen implant market.

Market Segmentation

Based on the application	Ocular Surgery Orthopaedic Surgery Dental Surgery Vascular Surgery General Surgery
Based on the type	Collagen Film/sheet/disc ·Collagen shields ·Collagen sponges ·Collagen Gel/hydrogel ·Collagen Pellet
Based on the end-users	Hospitals ·Ambulatory Surgical Centers ·Others.
Based on the region	North America Latin America Europe South Asia East Asia Oceania The Middle-East & Africa (MEA)

The dental surgery segment is expanding rapidly in the bioresorbable collagen implant market due to certain advantages of implants in dentistry. Growing concern for bone diseases and orthopaedic surgeries, the rising elder population is anticipated to grow orthopaedic surgery segment in bioresorbable collagen implant market. Based on type, collagen hydrogels segment holds a larger share in the bioresorbable collagen implant market followed by collagen films, disc and shields segment. Based on end-users Ambulatory Surgical Centers segment is dominating the bioresorbable collagen implant market.

As per the American journal of sports medicine, almost 1 million orthopaedic implantable surgeries are executed in the U.S. annually and more than 400,000 surgeries in Europe region. Due to this North America is expected to dominate the bioresorbable collagen implant market followed by Europe. The Asia Pacific is also expected to have a rapid growth in the bioresorbable collagen implant market due to the increased in the investment of key company as well as advancement in the collagen implants manufacturing.

The key participants operating in the global Bioresorbable collagen implant Market are Biomatlante, Datum Dental Ltd., RTI Surgical, Active Implants, Geistlich Pharma AG, Orthonika, Stryker Corporation, Collagen Matrix Inc., Zimmer Biomet, Nobel Biocare, Biofixt, ACE Surgical Supply Co., Inc. and others

The report covers exhaustive analysis on:

• Bioresorbable collagen implant market Segments
• Bioresorbable collagen implant market Dynamics
• Historical Actual market Size, 2015 - 2019
• Bioresorbable collagen implant market Size & Forecast 2020 to 2030
• Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

To know more about delivery timeline for this report Contact Sales